226 related articles for article (PubMed ID: 9291751)
1. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.
Tong MJ; Lai LP; Murakami-Mori K
West J Med; 1997 Aug; 167(2):103-5. PubMed ID: 9291751
[No Abstract] [Full Text] [Related]
2. [Hepatitis C].
Moradpour D; Blum HE
Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
[TBL] [Abstract][Full Text] [Related]
3. PSG consensus statement on management of hepatitis C virus infection--2003.
Hamid S; Umar M; Alam A; Siddiqui A; Qureshi H; Butt J;
J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876
[No Abstract] [Full Text] [Related]
4. [Case of hepatocellular carcinoma due to interferon therapy of chronic hepatitis C].
Enomura H; Ogasawara M; Doi K; Endo T; Mori T; Matsuzaki O; Fujimoto Y; Takase K; Nakano T
Nihon Naika Gakkai Zasshi; 1997 Oct; 86(10):1961-3. PubMed ID: 9445884
[No Abstract] [Full Text] [Related]
5. [Hepatitis C].
Pache I; Gonvers JJ
Rev Med Suisse Romande; 2002 Oct; 122(10):507-12. PubMed ID: 12494784
[No Abstract] [Full Text] [Related]
6. Hepatitis C: diagnosis and treatment.
Scotiniotis I; Brass CA; Malet PF
J Gen Intern Med; 1995 May; 10(5):273-82. PubMed ID: 7542329
[No Abstract] [Full Text] [Related]
7. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
Kohli A
Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
[No Abstract] [Full Text] [Related]
8. Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C.
Miyano S; Togashi H; Shinzawa H; Sugahara K; Matsuo T; Takeda Y; Saito K; Saito T; Ishiyama S; Kaneko M; Takahashi T
J Gastroenterol Hepatol; 1999 Sep; 14(9):928-30. PubMed ID: 10535477
[TBL] [Abstract][Full Text] [Related]
9. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.
Venezia G; Licata A; Di Marco V; Craxì A; Almasio PL
Dig Liver Dis; 2005 Nov; 37(11):882-5. PubMed ID: 16169301
[TBL] [Abstract][Full Text] [Related]
10. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
Shiraha H; Iwasaki Y; Shiratori Y
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
[No Abstract] [Full Text] [Related]
11. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy.
Tokita H; Fukui H; Tanaka A; Kamitsukasa H; Yagura M; Harada H; Okamoto H
J Gastroenterol Hepatol; 2005 May; 20(5):752-8. PubMed ID: 15853990
[TBL] [Abstract][Full Text] [Related]
12. [Treatments for hepatitis virus C infections].
Pol S; Fontaine H; Vallet-Pichard A
Gastroenterol Clin Biol; 2001 Mar; 25(3):287-307. PubMed ID: 11395676
[No Abstract] [Full Text] [Related]
13. Primary biliary cirrhosis exacerbated by a course of acute hepatitis C and subsequent interferon therapy.
Yoshikawa M; Mimura M; Shiroi A; Kojima H; Fukui H; Sugimoto Y; Mochi T
Am J Gastroenterol; 2000 Sep; 95(9):2396-7. PubMed ID: 11007259
[No Abstract] [Full Text] [Related]
14. Current status of hepatitis C virus infection in Korea.
Suh DJ; Jeong SH
Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
[TBL] [Abstract][Full Text] [Related]
15. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
16. Resected cases of hepatocellular carcinoma detected after interferon therapy for chronic hepatitis C.
Kubo S; Nishiguchi S; Tamori A; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Kuroki T; Kinoshita H
Hepatogastroenterology; 2000; 47(34):1100-2. PubMed ID: 11020887
[TBL] [Abstract][Full Text] [Related]
17. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
[TBL] [Abstract][Full Text] [Related]
18. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
19. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
Shibata M; Yanaga K; Morizane T; Yanagawa T; Hirakawa M; Ueno Y; Esquivel CO; Mitamura K
J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma developed in a patient with chronic hepatitis C after the disappearance of hepatitis C virus due to interferon therapy.
Inoue M; Ohhira M; Ohtake T; Matsumoto A; Kawashima T; Fujimoto Y; Hasebe C; Ono M; Kohgo Y
Hepatogastroenterology; 1999; 46(28):2554-60. PubMed ID: 10522040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
